Point of Care Lipid Test Market

Report ID: SQMIG35A4075

BUY NOW GET SAMPLE REPORT

BUY NOW GET FREE SAMPLE

Point of Care Lipid Test Market Size, Share, and Growth Analysis

Q: What is the key market trend for Point of Care Lipid Test Market?

Digital Integration: Healthcare providers are increasingly embedding point‑of‑care lipid analysers within electronic medical records and telehealth platforms, enabling real‑time data transmission to clinicians. This seamless connectivity reduces diagnostic delays, supports personalized treatment adjustments, and enhances patient engagement. As interoperability standards mature, manufacturers are designing devices with built‑in connectivity modules and secure cloud interfaces, fostering collaborative care models that span hospitals, primary clinics, and remote monitoring networks, ultimately accelerating the shift toward data‑driven cardiovascular risk management for long‑term population health outcomes and sustainability.

Point of Care Lipid Test Market By Product Type (Instruments, Consumables), By Application (Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Familial Hypercholesterolemia, Others), By Indication, By End User, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A4075 | Region: Global | Published Date: July, 2026
Pages: 157 |Tables: 121 |Figures: 77

Format -

Point of Care Lipid Test Market Insights

Global Point Of Care Lipid Test Market size was valued at USD 689.68 Million in 2024 and is poised to grow from USD 736.58 Million in 2025 to USD 1246.78 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global point‑of‑care (POC) lipid test market centers on compact analyzers plus disposable cartridges that deliver quick cholesterol, triglyceride, and lipoprotein results at clinics, pharmacies, and even patients’ homes. The reason people care so much is basically the continued rise in cardiovascular disease, and the fact that risk assessment needs to happen fast, because the usual lab turnaround time just can’t keep up it.

Regulatory endorsement of guideline‑driven lipid monitoring has become the main factor behind the point of care lipid test market growth, since health authorities now expect dyslipidemia indicators to be reported during primary‑care visits . That expectation pushes health systems to invest in portable analyzers, and this in turn reduces per‑test costs , and makes access easier for underserved groups. A useful example would be a partnership between a pharmacy chain and a POC device manufacturer , where 1,200 units were installed across outlets. After that, there was about a 30 % jump in statin initiation among screened patients. The larger dataset then feeds reimbursement models that reward preventive testing, so it becomes a cycle , that speeds adoption and also creates room for digital integration with tele‑health.

How is AI transforming the point‑of‑care lipid test market?

AI is reshaping the point‑of‑care lipid testing market outlook by embedding smarter algorithms into handheld analyzers, so cholesterol profiles can be interpreted quickly, without needing a full laboratory setup . Machine‑learning models calibrate outcomes using patient history, and that helps accuracy, while also reducing repeat testing that no one wants . Real‑time data connectivity lets clinicians get instant alerts when values are abnormal, which supports more proactive disease management. As a result, these features are pushing broader adoption across primary care, where fast decisions matter , and the market influence grows beyond traditional hospital labs. AI integration also helps workflow, cutting down manual steps, so staff can focus more on patient interaction which overall improves service quality.

Abbott announced in June 2024 an AI‑enhanced PoC lipid analyzer that provides instant risk scores, which helps accelerate diagnosis and supports market growth through improved efficiency.

Market snapshot - (2026-2033)

Global Market Size

USD 689.68 Million

Largest Segment

Consumables

Fastest Growth

Instruments

Growth Rate

6.8% CAGR

Point of Care Lipid Test Market ($ Mn)

Country Share for North America Region (%)

To get more insights on this market click here to Request a Free Sample Report

Point of Care Lipid Test Market Segments Analysis

The global point-of-care lipid test market is segmented by product type, application, indication, end user and region. Based on product type, the market is segmented into Instruments and Consumables. Based on application, the market is segmented into Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Familial Hypercholesterolemia and Others. Based on indication, the market is segmented into Lipid & Lipoprotein Disorders, Atherosclerosis, Liver & Renal Diseases, Diabetes Mellitus and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

What role do instruments play in transforming the point of care lipid test market?

As per the point-of-care lipid test market analysis, the Instruments segment runs ahead, because point of care lipid testing depends on accurate, portable analytical platforms that can give quick results right at bedside. Clinicians tend to lean toward devices that mesh well with electronic health records, so they look reliable and easy to operate, and that basically keeps adoption climbing across different care locations. Being able to produce quantitative lipid profiles without needing a central laboratory is what pushes hospitals and clinics toward instrument solutions, which then locks in strong market leadership in the global space.

However, the Consumables segment shows up as the fastest-moving part of the point-of-care lipid test market. Improvements in cartridge design and reagent stability are bringing down the cost per test, while also broadening the test menu, which helps invite more clinical use. This momentum is what supports wider uptake and also opens up fresh revenue routes for manufacturers.

How are hospitals influencing adoption of point of care lipid testing?

According to the point-of-care lipid test market forecast, the Hospitals segment leads because big health systems need broad lipid profiling to manage cardiovascular risk across inpatient and outpatient programs. Their purchasing workflows often prefer devices that come with dependable quality control, clean data integration, and service agreements, so performance stays consistent and compliance stays intact. When the high volume testing and the constant need for faster decisions added, the hospital preference for point of care solutions becomes even stronger, and it helps keep their dominant spot as the clinical landscape keeps evolving.

Meanwhile, the Home Care Settings segment is gaining the most noticeable growth pace in the point of care lipid test market. Portable devices with user friendly interfaces allow patients to keep track of lipid levels remotely, which lines up with telehealth expansion and also supports patient empowerment. That rise encourages manufacturers to design simpler kits to use , and this helps them grow distribution channels while pushing market reach beyond facilities and into more everyday environments.

Point of Care Lipid Test Market By Product Type

To get detailed segments analysis, Request a Free Sample Report

Point of Care Lipid Test Market Regional Insights

Why does North America Dominate the Global Point of Care Lipid Test Market?

As per the point-of-care lipid test market regional forecast, the dominance of North America comes from this mix of more advanced healthcare delivery models, a ton of insurance coverage that helps make faster diagnostic uptake happen, and a regulatory setup that pushes new ideas. Big manufacturers often say they like the environment because there are research bodies working together, and people have this preventive health mindset that basically pulls demand toward quick lipid profiling. When electronic health record integration and telemedicine platforms added, it helps the market keep moving, also because cardiovascular risk reduction stays a high priority so utilization keeps going in different clinical places and not just one niche.

United States Point of Care Lipid Test Market

The Point of Care Lipid Test sector in the United States tends to perform well due to a mature health setup, reimbursement routes that are widespread, and a strong level of clinician awareness about cardiovascular risk. The market is boosted by big hospital networks, coordinated primary care practices, and this habit of making rapid diagnostic choices. There are also solid research collaborations and pioneering device manufacturers, plus digital health tools that make data capture and patient handling smoother.

Canada Point of Care Lipid Test Market

The Point of Care Lipid Test Market outlook in Canada is shaped by a universal health system that supports access to diagnostic tools fairly across provinces. Provincial reimbursement programs back the rollout of quick lipid testing in community clinics and primary care locations. Preventive care is heavily stressed, and that goes along with collaborative research efforts, so clinicians get more comfortable adopting it. On top of that, government backing for innovative health technologies stays strong, and there’s a focus on plugging point of care findings into larger health information networks.

What is Driving the Rapid Expansion of Point of Care Lipid Test Market in Europe?

Europe’s quick point-of-care lipid test market penetration is driven by regulations that are more aligned, so bringing a product to market feels less complicated, plus public health programs that are leaning into early cardiovascular risk detection. National health services increasingly favor point of care solutions to ease lab delays and improve patient flow. Clinical guideline support, together with innovation hubs and a real push for digital health integration, makes it easier for the market to keep growing. The region’s stable healthcare systems, paired with proactive policy structures, speeds up adoption in both hospitals and outpatient settings.

Germany Point of Care Lipid Test Market

The Point of Care Lipid Test industry in Germany is anchored by a health insurance structure that reimburses rapid diagnostic work, so uptake among clinicians becomes much easier. The market also benefits from strict clinical guidelines, these emphasize checking lipid levels early for cardiovascular prevention. There are established lab networks, and a research collaboration culture, and that supports the rollout of advanced point of care devices. Integration with electronic health records helps keep the data consistent and improves clinical decision support.

United Kingdom Point of Care Lipid Test Market

The Point of Care Lipid Test Market in the United Kingdom sees faster growth because national health service initiatives encourage early identification of lipid abnormalities. The focus on outpatient testing, plus digital health platforms, allows point of care results to slide into patient pathways without a lot of friction. The market is also energized by deals between healthcare providers and tech firms, which nudges innovation forward and widens access across primary care settings.

France Point of Care Lipid Test Market

The Point of Care Lipid Test Market in France is starting to become a key area for preventive health strategies, supported by policy changes that encourage quick diagnostic adoption. Clinician awareness of cardiovascular risk factors is growing, alongside an expanding network of community health centers, so momentum keeps building. Collaborative research programs, plus supportive reimbursement conditions, make it easier to fold point of care testing into everyday clinical routines.

How is Asia Pacific Strengthening its Position in Point of Care Lipid Test Market?

Asia Pacific is tightening its grip through demographic pressure s, a tech enthusiasm, and health policy promises that are being kept more seriously now. There’s this population that’s getting more health aware, plus the cities are growing fast, so people want diagnostic stuff that’s easy and convenient, not only the classic lab routine. Governments are setting up innovation ecosystems and nudging public‑private partnerships, so that devices can reach the field quicker. The region is also quick to pick up mobile health platforms and to weave point of care data into bigger health management systems, which makes its position in the emerging market look stronger.

Japan Point of Care Lipid Test Market

The Point of Care Lipid Test Market in Japan is largely pushed by an aging population, and that situation makes cardiovascular health a main priority. There’s a solid regulatory environment, and it helps newer diagnostic devices enter the market without too much delay. Hospitals and clinics are starting to use point of care testing more, mainly to keep patient flow smoother, and to reduce bottlenecks. On top of that, government programs for preventive care, along with digital health integration, increase clinical comfort and adoption. Research institutions, working together, also keep improving testing capabilities, with updated methods and better performance.

South Korea Point of Care Lipid Test Market

The Point of Care Lipid Test Market in South Korea does well because the environment is very tech‑oriented, and it actually likes mobile health solutions and fast diagnostic tools. National health policies encourage earlier detection of lipid disorders, so adoption expands across hospitals and community health centers. The market also gets a boost from partnerships that medical device companies form with healthcare providers, and that helps advanced point of care platforms roll out smoothly. These platforms match the country’s emphasis on prevention, plus the overall direction toward digital innovation and smarter clinical workflows.

Point of Care Lipid Test Market By Geography

Largest
Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Point of Care Lipid Test Market Dynamics

Drivers

Increasing Chronic Disease Burden

Drivers that keep showing up, are the fact that chronic disease burdens are going up, and healthcare providers start looking for faster, on-site lipid checks to make therapeutic choices sooner. With point‑of‑care platforms, results can show immediately, without leaning on a central lab ,so patients don’t have to wait around, and clinicians can move quicker with their treatment plan. That practical speed can lift adherence too , and it supports a more preventive style of disease management, even when clinical resources are mixed or very different from one setting to another. Because of that, the “real” clinical importance of decentralized lipid testing tends to look stronger, and that makes hospitals, primary care clinics, and community health initiatives more interested. In turn, the adoption of point‑of‑care lipid solutions spreads wider, across regions, and it helps strengthen cardiovascular risk tracking on a global scale.

Advancements In Portable Technology

Then there is the tech side, where recent progress has basically shrunk the analytical parts, so instead of big equipment offer compact units. These newer systems bring together nanomaterials, microfluidic channels, and wireless connectivity in one place, while still aiming for laboratory‑grade accuracy. The benefit is that they’re simpler to run, they require less upkeep, and they can transmit information straight to electronic health records. So patient monitoring looks more complete, not just a quick snapshot. As clinicians use these devices and feel they are more steady, and easier to work with, confidence rises. That encouragement pushes point‑of‑care lipid testing into everyday routines, in outpatient environments, emergency departments , and even remote health programs, which supports deeper market penetration and can enable more coordinated care models worldwide.

Restraints

High Device Cost Barriers

The sophisticated elements needed for dependable lipid testing, like precision sensors and integrated data analytics, make the devices land at a higher price. That “premium” price tag becomes a real barrier for small clinics and facilities with tight budgets , since funds usually go first toward core services rather than advanced diagnostics. As a result, adoption stays uneven, and when money is limited, implementation tends to be pushed back. This slows overall market expansion, and it reduces how far decentralized lipid testing solutions can go, especially across rural and underserved locations across the world.

Regulatory Approval Complexity

Point‑of‑care lipid devices have to meet tough regulatory expectations, to confirm accuracy, safety, and clinical dependability. Usually that means extensive validation studies, plus multi-stage review steps in several jurisdictions. Those strict requirements drag out time‑to‑market, and they also increase development expenses, which makes some manufacturers hesitant to pursue fresh product launches. So even if there’s clinical demand, delays in availability reduce product variety, and they can slow adoption in emerging markets. All of this can dampen overall market growth, and it introduces some uncertainty for investors and healthcare providers, too.

Request Free Customization of this report to help us to meet your business objectives.

Point of Care Lipid Test Market Competitive Landscape

The competitive landscape is shaped by more and more rivalry among diagnostic manufacturers trying to grab that expanding point of care lipid testing segment. A lot of companies are pushing technology integration, this can be seen in recent partnerships that embed lipid panels into handheld analyzers, and also in strategic acquisitions that consolidate regional players. The goal is usually to widen distribution networks, and at the same time enhance the assay portfolios, so they can respond to the rising craving for quick cholesterol checks in decentralized environments. Plus, they’re trying to stand out with better accuracy, and added connectivity.

Top Player’s Company Profile

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
Becton Dickinson and Company
Quidel Corporation (QuidelOrtho)
Bio-Rad Laboratories Inc.
Horiba ABX SAS
Randox Laboratories Ltd.
Sekisui Diagnostics LLC
Fisher Scientific International Inc.
Nova Biomedical Corporation
SD Biosensor Inc.
Sinocare Inc.
VivaChek Biotech (Hangzhou) Co. Ltd.
Callegari Srl

Recent Developments in the Point of Care Lipid Test Market

In December 2025, Truvian Health got U.S. FDA 510(k) clearance for its Lipids assay on the automated Truvian Bench-top Blood Testing System. This approval reinforces the trend toward compact, multi-analyte near‑patient diagnostic platforms that can deliver quick lipid testing along with other routine blood tests, and fits the workflow that clinicians already use.
In February 2025, SD Biosensor’s Sommet CURO L7 System received a U.S. FDA CLIA Waiver for its lipid panel and glucose testing system. With that waiver, the analyzer can be used in physician offices, pharmacies, retail clinics, and other decentralized healthcare sites, which should meaningfully increase its commercial reach in the market.
In January 2025, Roche received U.S. FDA 510(k) clearance for its Lipoprotein(a) [Lp(a)] assay in molar units. While it was intended mainly for laboratory use rather than true point-of-care testing, this approval still points to the industry’s increased attention on advanced cardiovascular biomarkers, and that could end up influencing how future POC lipid testing platforms get developed.

Point of Care Lipid Test Key Market Trends

Digital Integration: Healthcare providers are, increasingly embedding point‑of‑care lipid analysers into electronic medical records and even telehealth platforms, so that data can travel in real time to clinicians. It feels like that “smooth” connectivity can cut down diagnostic lags, helps clinicians fine tune personalized treatment, and also boosts patient involvement. And, as interoperability standards keep getting more mature, device makers are building connectivity modules right inside the instruments, plus secure cloud interfaces. That setup then supports cooperative care models across hospitals , primary clinics , and remote monitoring networks, and in the end, it pushes the whole move toward data‑led cardiovascular risk management , for long‑term population health results and sustainability.

Home‑Testing Acceptance Surge: People are also leaning into self‑administered lipid testing as part of bigger wellness routines, mostly because heart disease risk feels closer than before, and because it offers results quickly. Manufacturers answer with easy to use kits, with more simplified sample collection, and visual readouts that are understandable at a glance. A lot of them also add mobile app integration, that guides interpretation, and suggests what to do next. This empowerment encourages more frequent checking, reduces the need to keep visiting labs, and it creates new data feeds for insurers and providers. Then those groups can adapt preventive plans, and it builds a more proactive health culture globally.

Point of Care Lipid Test Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, the global point‑of‑care lipid test market is being pushed mainly by the growing load of long‑term cardiovascular disease, which basically urges clinicians to use quick bedside testing. At the same time, the rise in portable technology that pairs microfluidics with AI is adding extra momentum, and uptake goes up. A major limiting factor stays the high cost of advanced devices, because that expense narrows adoption in smaller clinics or places with fewer resources. North America still sits in the lead, mostly due to mature health‑care infrastructure, reimbursement routes that are already strong, and an early‑adopter mindset. By product type, the instruments segment is leading, because it stays essential for accurate, immediate results. And on the end‑user side, hospitals are the top driver, since they generate the most volume.

Report Metric	Details
Market size value in 2024	USD 689.68 Million
Market size value in 2033	USD 1246.78 Million
Growth Rate	6.8%
Base year	2024
Forecast period	(2026-2033)
Forecast Unit (Value)	USD Million
Segments covered	Product Type Instruments Single-Parameter Analyzers Multi-Parameter Analyzers Consumables Test Strips Cartridges Reagents Calibrators Application Hyperlipidemia Hypertriglyceridemia Tangier Disease Familial Hypercholesterolemia Others Indication Lipid & Lipoprotein Disorders Atherosclerosis Liver & Renal Diseases Diabetes Mellitus Others End User Hospitals Diagnostic Laboratories Clinics Home Care Settings
Regions covered	North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered	Abbott Laboratories F. Hoffmann-La Roche Ltd. Siemens Healthineers AG Becton Dickinson and Company Quidel Corporation (QuidelOrtho) Bio-Rad Laboratories Inc. Horiba ABX SAS Randox Laboratories Ltd. Sekisui Diagnostics LLC Fisher Scientific International Inc. Nova Biomedical Corporation SD Biosensor Inc. Sinocare Inc. VivaChek Biotech (Hangzhou) Co. Ltd. Callegari Srl MiCoBio Inc. Menarini Group Cobas (Roche) Orion Diagnostica Oy Cholestech Corporation
Customization scope	Free report customization with purchase. Customization includes:- Segments by type, application, etc Company profile Market dynamics & outlook Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

Exhibit: Executive Summary – Chart on Market Overview
Exhibit: Executive Summary – Data Table on Market Overview
Exhibit: Executive Summary – Chart on Point of Care Lipid Test Market Characteristics
Exhibit: Executive Summary – Chart on Market by Geography
Exhibit: Executive Summary – Chart on Market Segmentation
Exhibit: Executive Summary – Chart on Incremental Growth
Exhibit: Executive Summary – Data Table on Incremental Growth
Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
- Exhibit: Data Table on Point of Care Lipid Test Market size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Regulatory Landscape
- Exhibit: Data Table on regulation from different region
SWOT Analysis
Porters Analysis
- Competitive rivalry
  - Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
  - Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
  - Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
  - Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
  - Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Market Size by Region

Chart on Market share by geography 2021-2027 (%)
Data Table on Market share by geography 2021-2027(%)
North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- France
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- India
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
  - Exhibit: Chart on Market share 2021-2027 (%)
  - Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

Competitive Landscape
- Total number of companies covered
  - Exhibit: companies covered in the report, 2021
- Top companies market positioning
  - Exhibit: company positioning matrix, 2021
- Top companies market Share
  - Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Point of Care Lipid Test Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Point of Care Lipid Test Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Point of Care Lipid Test Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Point of Care Lipid Test Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

License Type Top market research company in USA

File Type

$5,300

BUY NOW

ADD TO CART

REQUEST FOR SAMPLE

GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The competitive landscape is shaped by intensified rivalry among diagnostic manufacturers seeking to capture the expanding point‑of‑care lipid testing segment. Companies are accelerating technology integration, exemplified by recent partnerships that embed lipid panels into handheld analyzers, while strategic acquisitions are consolidating regional players to broaden distribution networks and enhance assay portfolios. These moves aim to meet rising demand for rapid cholesterol assessment in decentralized settings and to differentiate offerings through improved accuracy and connectivity. 'Abbott Laboratories', 'F. Hoffmann-La Roche Ltd.', 'Siemens Healthineers AG', 'Becton Dickinson and Company', 'Quidel Corporation (QuidelOrtho)', 'Bio-Rad Laboratories Inc.', 'Horiba ABX SAS', 'Randox Laboratories Ltd.', 'Sekisui Diagnostics LLC', 'Fisher Scientific International Inc.', 'Nova Biomedical Corporation', 'SD Biosensor Inc.', 'Sinocare Inc.', 'VivaChek Biotech (Hangzhou) Co. Ltd.', 'Callegari Srl', 'MiCoBio Inc.', 'Menarini Group', 'Cobas (Roche)', 'Orion Diagnostica Oy', 'Cholestech Corporation'

Healthcare providers are increasingly seeking rapid, on‑site lipid assessments to support timely therapeutic decisions, and point‑of‑care platforms enable immediate result availability without central laboratory dependence. This convenience reduces patient waiting times, enhances adherence to treatment protocols, and facilitates proactive disease management in diverse clinical settings. Consequently, the perceived clinical value of decentralized lipid testing strengthens demand among hospitals, primary care clinics, and community health programs, driving broader adoption of point‑of‑care lipid solutions globally and improving overall cardiovascular risk monitoring worldwide.

Digital Integration: Healthcare providers are increasingly embedding point‑of‑care lipid analysers within electronic medical records and telehealth platforms, enabling real‑time data transmission to clinicians. This seamless connectivity reduces diagnostic delays, supports personalized treatment adjustments, and enhances patient engagement. As interoperability standards mature, manufacturers are designing devices with built‑in connectivity modules and secure cloud interfaces, fostering collaborative care models that span hospitals, primary clinics, and remote monitoring networks, ultimately accelerating the shift toward data‑driven cardiovascular risk management for long‑term population health outcomes and sustainability.

Why does North America Dominate the Global Point of Care Lipid Test Market? |@12

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Request Customization

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.